Description: Ovoca Bio plc focuses on development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing Libicore, a medication for treatment of female sexual dysfunction. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was founded in 1985 and is based in Dublin, Ireland.
Home Page: ovocabio.com
OVB Technical Analysis
17 Pembroke Street Upper
Dublin,
2
Ireland
Phone:
353 1 661 9819
Officers
| Name | Title |
|---|---|
| Mr. Kirill Andreyevich Golovanov | Interim Chairman & CEO |
| Reneta Nikolova | Corp. Sec. |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.5857 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 10 |